A detailed history of Northern Trust Corp transactions in Cv Rx, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 133,212 shares of CVRX stock, worth $1.95 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
133,212
Previous 95,716 39.17%
Holding current value
$1.95 Million
Previous $1.15 Million 2.27%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$7.15 - $12.37 $268,096 - $463,825
37,496 Added 39.17%
133,212 $1.17 Million
Q2 2024

Aug 14, 2024

BUY
$6.49 - $19.2 $14,031 - $41,510
2,162 Added 2.31%
95,716 $1.15 Million
Q1 2024

May 14, 2024

SELL
$17.99 - $30.49 $29,557 - $50,095
-1,643 Reduced 1.73%
93,554 $1.7 Million
Q4 2023

Feb 13, 2024

BUY
$11.67 - $33.01 $54,218 - $153,364
4,646 Added 5.13%
95,197 $2.99 Million
Q3 2023

Nov 13, 2023

SELL
$13.56 - $18.47 $24,652 - $33,578
-1,818 Reduced 1.97%
90,551 $1.37 Million
Q2 2023

Aug 11, 2023

BUY
$8.57 - $15.44 $630,040 - $1.14 Million
73,517 Added 389.97%
92,369 $1.43 Million
Q4 2022

Feb 13, 2023

BUY
$8.94 - $18.35 $33,435 - $68,629
3,740 Added 24.75%
18,852 $345,000
Q3 2022

Nov 14, 2022

BUY
$6.12 - $9.5 $20,091 - $31,188
3,283 Added 27.75%
15,112 $141,000
Q2 2022

Aug 12, 2022

SELL
$4.7 - $7.22 $371,788 - $571,130
-79,104 Reduced 86.99%
11,829 $71,000
Q1 2022

May 13, 2022

BUY
$5.62 - $12.37 $76,847 - $169,147
13,674 Added 17.7%
90,933 $544,000
Q4 2021

Feb 08, 2022

BUY
$10.65 - $18.61 $37,882 - $66,195
3,557 Added 4.83%
77,259 $945,000
Q3 2021

Nov 15, 2021

BUY
$14.65 - $26.07 $1.08 Million - $1.92 Million
73,702 New
73,702 $1.22 Million

Others Institutions Holding CVRX

About CVRx, Inc.


  • Ticker CVRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 20,576,200
  • Market Cap $301M
  • Description
  • CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The co...
More about CVRX
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.